Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 17 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 9670141

    (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma

    Northwestern University · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  2. US 9669016

    Antiparasitic effect of Bis[3,5-Bis(Benzylidene)-4-Oxo-1-Piperidinyl]amide Derivatives

    The Board of Regents of the University of Texas System · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  3. US 9663790

    Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted May 30, 2017 · Expires May 25, 2037

    granted
  4. US 9663569

    Use of blocking agents of bone morphogenic protein (BMP) signalling for the treatment of neuroinflammatory and neurodegenerative diseases

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted May 30, 2017 · Expires May 25, 2037

    granted
  5. US 9650256

    Cerium oxide-aluminosilicate tubes nanocomposite and method of preparation

    TOVARISTVO Z OBMEZHENOU VIDPOVIDALNISTU “NANOMEDTRAST” · Granted May 16, 2017 · Expires May 11, 2037

    granted
  6. US 9629816

    Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  7. US 9624238

    4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  8. AR 103028

    COMPUESTOS ANTIBACTERIANOS CON ACCIÓN SOBRE TOPOISOMERASAS

    ACRAF [IT] · Granted Apr 12, 2017 · Expires Apr 7, 2037

    granted
  9. US 9610331

    Methods for hematopoietic precursor mobilization

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  10. US 9603820

    Ornithine aminotransferase inhibition with GABA analogues for treatment of hepatocellular carcinoma

    Northwestern University · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  11. US 9604976

    Antibacterial compounds

    SPERO GYRASE, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  12. US 9593136

    Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  13. US 9585975

    MRI contrast agents

    Northwestern University · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  14. US 9579407

    Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals

    Takeda Pharmaceutical Company Limited · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  15. US 9580428

    Compositions and methods for inhibiting viral polymerase

    BioCryst Pharmaceuticals, Inc. · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  16. US 9580472

    Anti-microbial peptides and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  17. US 9566355

    Bacteria-targeted magnetic resonance contrast agents

    Northwestern University · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  18. US 9555135

    Cobalt-based MRI contrast agent and imaging system

    The Board of Regents of the University of Texas System · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  19. US 9550756

    Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

    Takeda Pharmaceutical Company Limited · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  20. US 9545452

    Biomineral and metal binding liposomes, their synthesis, and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted
  21. US 9540642

    Compositions and methods for controlling arthropod parasite and pest infestations

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  22. US 9527841

    Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted
  23. US 9517230

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  24. US 9513289

    Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases

    The United Sates of America, as Represented by the Department of Veterans Affairs · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted